All
Doctor objects to AAD logo appearing on sun protection products
December 1st 2007The American Academy of Dermatology announced in May 2007 that it had launched its Seal of Recognition program, in which the Academy charges companies thousands of dollars for the right to display the Academy's logo on sun protection products that meet the Academy's criteria. Academy members who back the program say it is a noble cause that will greatly fuel the organization's skin cancer education efforts.
Can studies funded by manufacturers yield valid, objective results?
December 1st 2007With the decreases in government funding of medical trials, manufacturers of the products being tested finance more and more clinical trials, whether for medication, therapies or equipment. Tests are obviously needed to determine the effectiveness and safety of new products in order to make medical progress. That system, however, can put unpredictable pressure on physicians conducting the trials.
Your Web site: Do you need the bells and whistles?
December 1st 2007Websites range from those structured as online brochures to the more complicated interactive sites. Whether you need the bells and whistles of interaction depends on your goals, how much you want to spend and how much effort you plan to focus on the web.
Senators ponder ethical conflicts of doctor-drug company relationships
December 1st 2007Congress has been warned that many doctors are "on the take" from big pharmaceutical companies, which pay them in one way or another to prescribe their drugs to patients, and are "at risk of corruption" while endangering the lives of patients.
Defining terms: Dysyplastic debate continues
December 1st 2007In the Letters section of the October 2007 issue of Dermatology Times, both Craig G. Burkhart, M.D., and Michael H. Coverman, M.D., do not directly address two important points in the debate regarding "dysplastic" nevi. Clinical utility of a concept derives from its prognostic and therapeutic implications. Specifically, the utility of the concept of dysplastic nevi is that they are a significant risk factor for cutaneous melanoma.[1,2] This concept is analogous to hypercholesterolemia and hypertension being asymptomatic risk factors for cardiovascular disease and not diseases in and of themselves.
Data for anti-aging skincare lags behind consumer interest
December 1st 2007The antiaging skincare market continues to grow with topical and oral products containing novel ingredients being rapidly introduced. However, scientific evidence to demonstrate effects of these agents on the skin is often lacking.
JAAD online features help readers stay current in information age
December 1st 2007The online version of the Journal of the American Academy of Dermatology (JAAD) provides valuable aids for handling the challenges presented by the growing problem of information overload, according to Jeffrey D. Bernhard, M.D., editor.
Government grants help restore New Orleans' healthcare workforce
December 1st 2007The Louisiana Department of Health and Hospitals is awarding physicians and other needed health care providers who meet certain criteria and agree to work in Greater New Orleans for three years or more grants of up to $110,000 each. The program, however, has yet to secure a dermatologist.
Expert witnesses: Who Can Testify Against Me?
December 1st 2007Dr. Skin has been practicing dermatology for 20 years. He performs both medical and cosmetic treatments. Three years ago, he chose to desiccate plantar warts on the foot of a 32-year-old diabetic athlete. The sites became infected and, ultimately, an amputation of the patient's foot was required.